Closed consultation

How should we engage and involve patients and the public in our work

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

We are reviewing our approach to how we engage and involve patients in the work of the Medicines and Healthcare products Regulatory Agency (MHRA).

This consultation ran from
to

Consultation description

We want to adopt a more systematic approach to listening to and involving patients – ensuring that the patient voice is heard when safety issues, concerning medicines or medical devices, are identified and in the licensing of new medicines.

We also plan to do more to communicate about who we are and the results of our work.

We would like to hear from:

  • patients
  • patient group representatives
  • carers
  • healthcare professionals

By taking part you will help us identify what our priorities should be for patient engagement and involvement in the future.

Engagement activities

To support the consultation we held engagement events in September and October in Belfast, Cardiff, Glasgow and London.

Documents

Published 15 July 2019
Last updated 1 October 2019 + show all updates
  1. We have updated the details for the London event
  2. Updated details of the London event.
  3. Added a new Word document version of the consultation response questionnaire, specifically for organisations to complete.
  4. Removal of details of the Glasgow event.
  5. Removed Cardiff event information.
  6. Uploaded Word document version of consultation questionnaire in Welsh
  7. First published.